Feasibility and end-user perceptions of a novel digital care assistant and support program for people after stroke or transient ischemic attack (CAPS)

L. Allan, Jan Cameron, David Silvera‐Tawil, Jonathan Li, Marlien Varnfield, Vanessa Smallbon, Julia Bomke, Muideen T. Olaiya, Natasha A. Lannin, Dominique A. CadilhacEuropean 2024 · DOI

TL;DR

The CAPS program is a multi-modal digital health intervention—combining a mobile app, wearables, and a clinician portal—designed to help stroke and TIA survivors manage their recovery and prevent secondary events. This feasibility study demonstrates high patient engagement and usability, suggesting that a "closed-loop" digital assistant can successfully integrate into the daily lives of patients to support long-term self-monitoring.

What Problem Does This Paper Address?

After a stroke or transient ischemic attack (TIA), the risk of a secondary event remains high. Effective "secondary prevention" requires rigorous management of risk factors like blood pressure, physical activity, and medication adherence. However, transitioning from acute hospital care to community-based self-management is often a "cliff edge" for patients.

Existing solutions are often fragmented. The authors address this by testing the Care Assistant and support Program for people after Stroke (CAPS), a clinician-led digital ecosystem designed to bridge the gap between clinical oversight and patient daily life. The goal was to determine if such a complex, tech-heavy intervention is actually feasible and acceptable for both survivors and the clinicians who would theoretically manage them.

Methods

The researchers conducted a 12-week, open-label, single-group, mixed-methods evaluation.

  • The Tech Stack: The CAPS intervention consists of four integrated components:
  • A web-based clinician portal for monitoring.
  • SMS messages aligned with personal goals.
  • A mobile application for data entry and tracking.
  • A wearable device for passive data collection.
  • Evaluation: They used the System Usability Scale (SUS) to quantify app quality and conducted focus groups with ten clinicians (including neurologists, nurses, and GPs) to gather qualitative feedback on the program's design and delivery model.
  • Participants: Lived-experience participants were recruited via the Australian Stroke Clinical Registry (AuSCR).

Datasets

As a feasibility and human-factors study, the "datasets" involved are the participant cohorts and the telemetry from the CAPS platform:

  • Lived-experience cohort: 34 eligible participants (recruited from 600 invitations).
  • Clinician cohort: 10 professionals (3 nurses, 3 allied health, 2 neurologists, 1 stroke consultant, 1 GP).
  • Usage Data: Logs of health data reviews and measurement entries (e.g., blood pressure, steps) over the 12-week period.

Key Insights and Ideas

  • High "Stickiness" in a Clinical Population: Despite the challenges often associated with post-stroke recovery (e.g., cognitive or motor impairments), participants engaged with the app an average of twice per day. This suggests that the "digital assistant" model provides enough perceived value to overcome the friction of manual data entry.
  • The "Golden Window" for Intervention: Clinicians highlighted that the timing of the intervention is critical. Seven out of ten clinicians believed the program would be most effective if initiated within the first three months post-discharge, capitalizing on the period when patients are most motivated to make lifestyle changes.
  • Primary Care is the Hub: While stroke care often starts in specialized wards, six clinicians indicated that a GP-led multidisciplinary model is the most sustainable way to deliver this digital program long-term, rather than keeping it within the silo of hospital neurology departments.
  • Closing the Loop: The program isn't just a tracker; it's a communication tool. The integration of "goal-aligned SMS" suggests that personalized, automated feedback is a key driver of engagement.

Key Results

  • Usability: The CAPS app received a SUS rating of "Good" to "Excellent."
  • Engagement: Participants entered health measurements an average of 73 times over 12 weeks. More than 60% of participants maintained sustained usage until the end of the study.
  • Acceptability: Over 90% of participants reported that the program fitted well into their daily routines and helped with self-monitoring.
  • Future Intent: 76% of participants stated they would continue to use the program if it were publicly available.
  • Clinician Sentiment: 80% of participating clinicians had positive perceptions, specifically noting that the app captured "vital information" necessary for secondary prevention.

Limitations and Future Work

The most notable limitation is the recruitment yield: only 34 participants commenced the program out of 600 invitations. This suggests a potential selection bias toward more tech-savvy or highly motivated individuals, which may not represent the broader stroke survivor population.

Future Directions: * Feature Expansion: Clinicians recommended adding tracking for atrial fibrillation (AFib) and blood cholesterol to make the clinical data more comprehensive. * Phase II Trial: The authors are using these findings to inform the design of a Phase II randomized feasibility trial, which will likely focus on the GP-led delivery model and the three-month post-discharge window.

Summary updated

Abstract

Abstract Background The Care Assistant and support Program for people after Stroke (CAPS) or transient ischaemic attack (TIA) is a clinician-led program designed to improve the secondary prevention of stroke. The program combines person-centred goal setting and risk-factor monitoring through a web-based clinician portal, SMS goal-aligned messages, a mobile application (app), and a wearable device. We aimed to determine the feasibility of CAPS among people living with stroke or TIA, and clinicians who would deliver the program in future. Methods Open label single group pre-posttest mixed-methods evaluation of the 12-week program. Eligible lived-experience participants were recruited through the Australian Stroke Clinical Registry. Eligibility: diagnosis of stroke or TIA in preceding 6 months - 3 years, ≥18 years old, smartphone/tablet ownership, living in the community. Following surveys and interviews of lived-experience participants, ten clinicians experienced in stroke care were invited to participate in focus groups to discuss the program. We used descriptive statistics to evaluate feasibility outcomes, i.e. participant perceptions of usability, acceptability and satisfaction, and clinician perceptions on program design and delivery. Results From 600 invitations, 34 eligible participants commenced the program (27% female, 33% TIA, median 1.7 years from index event; one withdrew). Usability of the CAPS app was rated as ‘Good’ to ‘Excellent’ (System Usability Scale), with moderate sustained usage by study conclusion (>60%). Participants frequently reviewed their health data within the app (average twice a day/participant over 12 weeks), and entered their health measurements an average 73 times/participant. The majority (≥90%) of participants thought the program fitted well into their daily lives or helped engage them in self-monitoring, with 76% indicating they would use the program, if publicly available. Clinician participants included three nurses, three allied health professionals, two neurologists, a stroke consultant, and a general practitioner (GP) in focus groups. Overall, eight had positive perceptions of the CAPS program. Three clinicians indicated the measurements collected in the app captured "vital information", and five saw the value of CAPS to improve secondary prevention. Recommended modifications to the program included tracking atrial fibrillation and blood cholesterol. Seven believed participants would receive the most benefit from the program if delivered within three months post-discharge. Six indicated that GP-led multidisciplinary care was the best model to deliver CAPS. Conclusions The CAPS program was feasible to deliver and acceptable to people living with stroke or TIA. Clinicians saw the value of CAPS for secondary prevention, with feedback prompting further focus groups with GPs to develop the potential model of care. Findings have informed the design of a Phase II randomised feasibility trial.
BibTeX
@inproceedings{allan2024feasibility,
  author = {L. Allan and Jan Cameron and David Silvera‐Tawil and Jonathan Li and Marlien Varnfield and Vanessa Smallbon and Julia Bomke and Muideen T. Olaiya and Natasha A. Lannin and Dominique A. Cadilhac},
  title = {{Feasibility and end-user perceptions of a novel digital care assistant and support program for people after stroke or transient ischemic attack (CAPS)}},
  booktitle = {European},
  year = {2024},
  doi = {10.1093/eurheartj/ehae666.3567},
}
Figure